NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

4 hedge funds and large institutions have $5.23K invested in InVivo Therapeutics Holdings Corp in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.

Holders
4
Holders Change
-10
Holders Change %
-71.43%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$5.22K

Top Sellers

1
BlackRock
1
BlackRock
New York
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$0
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$0
4
TRCT
4
Tower Research Capital (TRC)
New York
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Goldman Sachs
1
Goldman Sachs
New York
$5.22K 23,741 +23,741 New
VL
2
Vima LLC
Michigan
$2 2 – –
BlackRock
3
BlackRock
New York
– – -34,714 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– – -31,238 Closed
Geode Capital Management
5
Geode Capital Management
Massachusetts
– – -18,677 Closed
TRCT
6
Tower Research Capital (TRC)
New York
– – -8,395 Closed
Morgan Stanley
7
Morgan Stanley
New York
– – -540 Closed
Wells Fargo
8
Wells Fargo
California
– – -24 Closed
Osaic Holdings
9
Osaic Holdings
Arizona
– – -5 Closed
ITIM
10
Indiana Trust & Investment Management
Indiana
– – -2 Closed
CTA
11
Colonial Trust Advisors
South Carolina
– – -2 Closed
PWA
12
Provenance Wealth Advisors
Florida
– – -1 Closed
UBS Group
13
UBS Group
Switzerland
– – -1 Closed
AF
14
Allworth Financial
California
– – -1 Closed
CFGS
15
Concourse Financial Group Securities
Alabama
– – – –
SWM
16
Sugarloaf Wealth Management
Georgia
$0 1 – –
Barclays
17
Barclays
United Kingdom
$0 2 +2 New